What Lonza Is and What It Does as a CDMO

Lonza is a contract development and manufacturing organization (CDMO) focused on serving the healthcare industry. In practical terms, that means pharmaceutical and biotech companies can hand Lonza part or all of the work of developing a product and manufacturing it, instead of building those capabilities entirely in-house. This model fits companies that need specialized process know-how, additional production capacity, or a partner to carry a program from development toward commercial supply.

What “CDMO” means

A CDMO combines two related service roles:

• Contract development: designing and optimizing how a product is made — for example, developing a manufacturing process, improving yield or scalability, and preparing for later production stages.
• Contract manufacturing: producing the product at an agreed scale and quality standard, whether for clinical trial supply or commercial distribution.

The “contract” part signals that the work is performed by an external partner under an agreement, rather than by the client’s own staff and facilities. The two halves are often connected: process development decisions shape how smoothly manufacturing later runs.

Lonza’s stated role

Lonza describes itself as the world’s leading CDMO dedicated to serving the healthcare industry. That stated focus matters for readers evaluating the company: its positioning is healthcare-oriented contract services, not general-purpose manufacturing across unrelated sectors.

Who typically uses a CDMO like Lonza

The main users are pharmaceutical and biotech companies. Typical situations include:

• A biotech with a promising candidate but no in-house manufacturing capability.
• A pharma company needing extra capacity or specialized process expertise.
• A team that wants development and manufacturing handled by one partner to reduce handoffs between organizations.

How to decide whether this model fits

Use a CDMO when the bottleneck is capability or capacity rather than strategy — for example, when you need process development you cannot staff internally, or production capacity you do not want to build. Keep the work in-house when the process itself is a core competitive asset you need to control closely, or when the program is small enough that internal resources suffice.

If you are evaluating Lonza specifically, start from its stated healthcare focus and confirm that the development and manufacturing services you need fall within that scope before assuming a fit.